CytomX Therapeutics Inc
(FRA:6C1)
€
2.942
+0.072 (+2.51%)
Market Cap: 648.65 Mil
Enterprise Value: 367.77 Mil
PE Ratio: 0
PB Ratio: 2.49
GF Score: 36/100 CytomX Therapeutics Inc (FRA:6C1) Transcripts
- 1